The evolution of patient management in infectious and autoimmune diseases in the post-COVID-19 era
Authors:
- 1 November 2025
- journal article
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 3(83),p. 254-259
Abstract
Aim: To examine the changes implemented and emerging trends in managing patients with autoimmune and infectious neurologic pathology in the postCOVID-19 period, with focus on clinical and epidemiological experience. Materials and Methods: A systematic literature review was carried out following PRISMA criteria, using Google Scholar and PubMed databases. Keywords included: "neuromuscular diseases", "infectious disease", "multiple sclerosis", "autoimmune diseases", "telemedicine", "post-Covid-19 era". Articles published between 2023-2025 were considered; 369 articles were initially identified, of which 24 were included after screening titles and abstracts. Results: Telemedicine and telerehabilitation have become important complementary tools for patients with multiple sclerosis and other autoimmune diseases, although limitations remain in terms of access and technological literacy. The use of digital devices and digital biomarkers for monitoring is increasing, but further validation is needed. In infectious pathology, after easing restrictions there is a notable rise in the incidence of bacterial and viral meningitis, partly due to decreased vaccination coverage. For autoimmune disease patients, challenges include adapting immunosuppressive or biologic therapies after SARS-CoV-2 infection, and ensuring multidisciplinary care. Conclusions: Management of autoimmune and infectious pathologies in the post-COVID-19 era requires more flexible and personalized care models, strengthening digital infrastructure, epidemiological surveillance and vaccination programs, as well as integrating digital biomarkers and multidisciplinary teams for optimal patient outcomes.Keywords
This publication has 24 references indexed in Scilit:
- The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, ChinaScientific Reports, 2025
- Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reductionNature Medicine, 2024
- COVID-19 and multiple sclerosis: challenges and lessons for patient careThe Lancet Regional Health - Europe, 2024
- Changing epidemic patterns of infectious diseases during and after COVID-19 pandemic in TaiwanJournal of Microbiology, Immunology and Infection, 2024
- Meningococcal Disease in the Post–COVID-19 Era: A Time to PrepareInfectious Diseases and Therapy, 2023
- Era of COVID-19 in Multiple Sclerosis CareNeurologic Clinics, 2023
- Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patientsThe Lancet Psychiatry, 2022
- Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysisNeurological Sciences, 2022
- Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based surveyNeurological Sciences, 2021
- The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological DisordersJAMA Neurology, 2020